75N93021F00002↗
Sri International received this contract from National Institutes of Health Niaid, National Institutes of Health: -$16.5K obligated so far for health r&d services; health care services; applied research. Its period of performance ended 2026-09-29.
Key facts · data as of Oct 23, 2026
- Recipient
- Sri International
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- -$16.5K
- Potential value
- $11.16M
- Ends
- 2026-09-29
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75N93021F00002, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75N93021F00002_7529_75N93020D00011_7529
Sri International: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys · The follow-on: recompete brief
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING
Up for re-bid: ends 2026-09-29. Recompete brief → · 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases ↗
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition
- Pricing
- Cost plus fixed fee
- How it was bought
- Single-award IDIQ · under 75N93020D00011
- Where the work is
- San Mateo, CA · district CA-16
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
1 subaward totaling $372.5K (37253600.0% of what was obligated), as Sri International reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| The Medical College of Wisconsin, Inc. | $372.5K | 1 | WI | 2024-04-15 | 2024-04-15 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2024-04-15 | The Medical College of Wisconsin, Inc. | $372.5K | PERFORM A NON-GLP EFFICACY LUNG-DEARE STUDY IN WAG/RIJCMCR RATS TO TEST A CANDIDATE DRUG AS COUNTERMEASURE FOR RADIATION PROTECTION. THE PRIMARY ENDPOINT WILL BE SURVIVAL AND SECONDARY ENDPOINTS WILL INCLUDE BLOOD… |
Every action
5 actions since 2023-08-31. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-10 | P00009 | Funding only | -$16.5K | ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMS |
| 2026-07-21 | P00008 | Administrative change | $117.9K | ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMS |
| 2026-07-16 | P00007 | Funding only | -$117.9K | TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| 2025-06-17 | P00006 | Administrative change | $0 | ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING |
| 2023-08-31 | P00005 | Administrative change | $0 | ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗